A United States-based company, Moderna, has recorded a positive result in their first COVID-19 vaccine test on humans.
The biotechnology company revealed it has successfully carried out first coronavirus vaccine test carried out in eight human patients.
The company said it plans to launch a large clinical trial in July to confirm the effectiveness of the vaccine.
According to NY Times , Tal Zaks, Moderna’s chief medical officer says if the trials go well, a vaccine could become available for widespread use by the end of this year or early 2021.
“These interim Phase 1 data, while early, demonstrate that vaccination with mRNA-1273 elicits an immune response of the magnitude caused by natural infection starting with a dose as low as 25 µg,” Zaks also said.
“When combined with the success in preventing viral replication in the lungs of a pre-clinical challenge model at a dose that elicited similar levels of neutralising antibodies, these data substantiate our belief that mRNA-1273 has the potential to prevent COVID-19 disease and advance our ability to select a dose for pivotal trials.”
Stéphane Bancel, chief executive officer of Moderna, added that the company is aiming to scale up manufacturing “so we can maximise the number of doses we can produce to help protect as many people as we can from SARS-CoV-2.”
The US Food and Drug Administration already gave the company approval to begin the phase two clinical trials.
What do you think? Please drop comments below